UsmanBaberMD
Cardiology • Oklahoma City, OKAdult Congenital Heart Disease, Interventional Cardiology
Assistant Professor, Medicine, Icahn School of Medicine at Mount Sinai
Dr. Baber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Stanton L Young Blvd
Oklahoma City, OK 73104Phone+1 405-271-4742
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Interventional Cardiology, 2010 - 2011- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2007 - 2010
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2004 - 2007
University of Texas Southwestern Medical SchoolClass of 2004
Certifications & Licensure
OK State Medical License 2020 - 2025
NY State Medical License 2007 - 2021- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- The Charlson comorbidity index and outcomes after cardiac surgery: Look beyond the heart.Khawaja Hassan Akhtar, Yusra Minahil Nasir, Zain Ul Abideen Asad, Usman Baber
International Journal of Cardiology. 2024-12-15 - Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischemic events after percutaneous coronary intervention: A sub-study of the TWILIGHT ...Usman Baber, Davide Cao, Timothy Collier, Samantha Sartori, George Dangas
European Heart Journal. Cardiovascular Pharmacotherapy. 2024-10-17 - 5 citationsDe-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and in...Marco Valgimigli, Sung-Jin Hong, Felice Gragnano, Konstantina Chalkou, Anna Franzone
Lancet. 2024-09-07
Journal Articles
- Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent ImplantationMitchell Krucoff, Usman Baber, JAMA Cardiology
- Temporal Trends, Determinants, and Impact of High-Intensity Statin Prescriptions After Percutaneous Coronary InterventionGeorge Dangas, Serdar Farhan, Samin Sharma, Jason C Kovacic, Nitin Barman, Pedro Moreno, Joseph Sweeny, Birgit Vogel, Usman Baber, Roxana Mehran, ScienceDirect
- Determinants of Significant Out-of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary InterventionJoseph Sweeny, George Dangas, Usman Baber, Serdar Farhan, Birgit Vogel, Samin Sharma, Nitin Barman, Gennaro Giustino, Thrombosis and Haemostasis
- Join now to see all
Lectures
- Duration of Dual Antiplatelet Therapy After PCICRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCICRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- TWILIGHT: A Deep DiveCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- Join now to see all
Press Mentions
High Consumption of Coffee Could Put Your Heart at Risk, Study FindsAugust 17th, 2024- OU Health Milestone with Catheter-Based Mitral Valve RepairMarch 14th, 2023
- ‘Common’ Medication Nonadherence in CV Trials Impacts Outcomes, Regardless of InterventionAugust 15th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
